Use of glucosidase inhibitors for therapy of mucovisidosis

摘要

A treatment of cystic fibrosis by administration of a pharmaceutically acceptable amount of the glucosidase inhibitor NB-DMJ (N-butyldeoxy-mannojirimycin).